Clinical trial
A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren…
NCT00219102 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00219102 |
|---|---|
| Title | A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients |
| Official title | A 12-week, Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy & Safety of Aliskiren in Patients With Diabetes & Hypertension Not Adequately Responsive to the Combination of Valsartan 160 mg & Hydrochlorothiazide 25 mg |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetes |
| Intervention type | Drug |
| Interventions | aliskiren |
| Enrollment | 336 |
| Start date | Jun 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 11, 2020 |
| Countries | Belgium, Romania, Spain, Sweden, Switzerland, Ukraine, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: